Guidance

Pneumococcal Vaccine: Handling the change in product manufacturer and presentation

Summary guidance for national authorities and immunization programme managers for the switch from GlaxoSmithKline Biologicals SA Synflorix® (PCV 10) to Pfizer Prevenar13® vaccine (PCV 13)

Languages

  • Portuguese

Publication year

2017

Type

Guidance

Was this useful?
Log in to vote

Added by: Géraldine Nemrod

Added on: 2020-10-28 01:58:53

Hits: 2413

Uploaded file

PneumococcalVaccineSwitchNote_March2016FINAL.zip

Click to Download